Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Better results were observed even in people with increased portal hypertension.
Experts predict that more than a million people could die from liver cancer worldwide in 2040.
Women and young adults saw especially large increases between 2019 and 2021.
Current guidelines recommend antiviral treatment regardless of alcohol use.
Black people make up only 6% and Latino people make up 5% of participants in cirrhosis trials in the United States.
Diabetes and a large waist circumference are predictors of liver fat accumulation and fibrosis.
Liver cancer is now less likely to be caused by hepatitis B or C, but more likely to be caused by fatty liver disease or alcohol.
Researchers saw a particularly alarming increase in deaths from alcohol-related cirrhosis in people ages 24 to 35.
Heavy alcohol use among people with hepatitis B or C increased the risk of liver cancer.
A steep rise in drug overdose deaths during the pandemic led to greater availability of donor organs.
People with liver disease who took fewer steps per day counts were more likely to require hospitalization.
Higher daily alcohol consumption was linked to greater risk for MAFLD.
Three checkpoint inhibitors reduce the risk of death for patients with hard-to-treat liver and biliary tract cancers.
A majority of people with alcohol-related liver cirrhosis may have normal ALT levels.
Heavy alcohol use during the pandemic was linked to a rise in waiting list registrations and transplants due to alcohol-related hepatitis.
People with HIV had fewer cirrhosis-related complications but greater healthcare utilization.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.